These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 29917205

  • 21. Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Kidney Transplant Recipients with Post-transplant Diabetes Mellitus (PTDM)- a Systematic Review and Meta-Analysis.
    Abdelaziz TS, Ali AY, Fatthy M.
    Curr Diabetes Rev; 2020; 16(6):580-585. PubMed ID: 30907326
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of the addition of a dipeptidyl peptidase-4 inhibitor to insulin therapy in patients with type 2 diabetes: A systematic review and meta-analysis.
    Kim YG, Min SH, Hahn S, Oh TJ, Park KS, Cho YM.
    Diabetes Res Clin Pract; 2016 Jun; 116():86-95. PubMed ID: 27321321
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, placebo-controlled study (TROICA study).
    Ahn CH, Han KA, Yu JM, Nam JY, Ahn KJ, Oh TK, Lee HW, Lee DH, Kim J, Chung CH, Park TS, Kim BJ, Park SW, Park HK, Lee KJ, Kim SW, Park JH, Ko KP, Kim CH, Lee H, Jang HC, Park KS.
    Diabetes Obes Metab; 2017 May; 19(5):635-643. PubMed ID: 28026912
    [Abstract] [Full Text] [Related]

  • 27. Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40-week extension of the GUARD randomized study.
    Han SY, Yoon SA, Han BG, Kim SG, Jo YI, Jeong KH, Oh KH, Park HC, Park SH, Kang SW, Na KR, Kang SW, Kim NH, Jang Y, Kim B, Shin S, Cha DR.
    Diabetes Obes Metab; 2018 Feb; 20(2):292-300. PubMed ID: 28719008
    [Abstract] [Full Text] [Related]

  • 28. Dipeptydil peptidase-4 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials.
    Monami M, Iacomelli I, Marchionni N, Mannucci E.
    Nutr Metab Cardiovasc Dis; 2010 May; 20(4):224-35. PubMed ID: 19515542
    [Abstract] [Full Text] [Related]

  • 29. The long-term efficacy and safety of DPP-IV inhibitors monotherapy and in combination with metformin in 18,980 patients with type-2 diabetes mellitus--a meta-analysis.
    Liu X, Xiao Q, Zhang L, Yang Q, Liu X, Xu L, Cheng W.
    Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):687-98. PubMed ID: 24639059
    [Abstract] [Full Text] [Related]

  • 30. Tolerability of dipeptidyl peptidase-4 inhibitors: a review.
    Richard KR, Shelburne JS, Kirk JK.
    Clin Ther; 2011 Nov; 33(11):1609-29. PubMed ID: 22071236
    [Abstract] [Full Text] [Related]

  • 31. The effects of dipeptidyl peptidase-4 inhibitors on kidney outcomes.
    O'Hara DV, Parkhill TR, Badve SV, Jun M, Jardine MJ, Perkovic V.
    Diabetes Obes Metab; 2021 Mar; 23(3):763-773. PubMed ID: 33269512
    [Abstract] [Full Text] [Related]

  • 32. Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis.
    Tricco AC, Antony J, Soobiah C, Hemmelgarn B, Moher D, Hutton B, Yu CH, Majumdar SR, Straus SE.
    Syst Rev; 2013 Jun 28; 2():47. PubMed ID: 23810103
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of dipeptidyl-peptidase-4 inhibitors and impact on β-cell function in Asian and Caucasian type 2 diabetes mellitus patients: A meta-analysis.
    Cai X, Han X, Luo Y, Ji L.
    J Diabetes; 2015 May 28; 7(3):347-59. PubMed ID: 25043156
    [Abstract] [Full Text] [Related]

  • 34. Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: systematic review and meta-analysis.
    Gooßen K, Gräber S.
    Diabetes Obes Metab; 2012 Dec 28; 14(12):1061-72. PubMed ID: 22519906
    [Abstract] [Full Text] [Related]

  • 35. Incretin therapies in the management of patients with type 2 diabetes mellitus and renal impairment.
    Dejager S, Schweizer A.
    Hosp Pract (1995); 2012 Apr 28; 40(2):7-21. PubMed ID: 22615074
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials.
    Rehman MB, Tudrej BV, Soustre J, Buisson M, Archambault P, Pouchain D, Vaillant-Roussel H, Gueyffier F, Faillie JL, Perault-Pochat MC, Cornu C, Boussageon R.
    Diabetes Metab; 2017 Feb 28; 43(1):48-58. PubMed ID: 27745828
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of different dipeptidyl peptidase-4 (DPP-4) inhibitors on metabolic parameters in patients with type 2 diabetes undergoing dialysis.
    Park SH, Nam JY, Han E, Lee YH, Lee BW, Kim BS, Cha BS, Kim CS, Kang ES.
    Medicine (Baltimore); 2016 Aug 28; 95(32):e4543. PubMed ID: 27512877
    [Abstract] [Full Text] [Related]

  • 38. Reduction in HbA1c with SGLT2 inhibitors vs. DPP-4 inhibitors as add-ons to metformin monotherapy according to baseline HbA1c: A systematic review of randomized controlled trials.
    Scheen AJ.
    Diabetes Metab; 2020 Jun 28; 46(3):186-196. PubMed ID: 32007623
    [Abstract] [Full Text] [Related]

  • 39. Real-world evaluation of glycemic control among patients with type 2 diabetes mellitus treated with canagliflozin versus dipeptidyl peptidase-4 inhibitors.
    Thayer S, Chow W, Korrer S, Aguilar R.
    Curr Med Res Opin; 2016 Jun 28; 32(6):1087-96. PubMed ID: 26938635
    [Abstract] [Full Text] [Related]

  • 40. A safety and tolerability profile comparison between dipeptidyl peptidase-4 inhibitors and sulfonylureas in diabetic patients: A systematic review and meta-analysis.
    Farah D, Leme GM, Eliaschewitz FG, Fonseca MCM.
    Diabetes Res Clin Pract; 2019 Mar 28; 149():47-63. PubMed ID: 30710655
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.